Safe Orthopaedics takes off on its spine implant advancement

Safe SA

21/12/2021 08:20

** Shares in Safe Orthopaedics  ALSAF.PA  jump 20% after the
medical technology group reported a group of surgeon evaluators
issued a positive view on its Sycamore spine implant
    ** The evaluation group gave very satisfactory conclusions
at three months on the new product with a reduction of pain
observed in post-surgery of about 65%, the group said
 urn:newsml:reuters.com:*:nFWN2T510B
    ** Sycamore, an implant designed to secure the treatment of
vertebral fractures and reduce the risk of adjacent fractures,
will be launched globally in January 2022, it added
    ** "The 2022 financial year therefore looks set to be a
dynamic one for Safe, as reflected in our estimates of sales
growth of over 70%," Midcap Partners notes
    ** Safe expects the FDA to approve Sycamore in H2 2022
before launching it in the U.S.
    ** The stock, which is heading for its best day in a year,
is down by around 51% YTD

 (Reporting by Juliette Portala)
 ((juliette.portala@tr.com))